New Spear-Phishing Attack Deploys DarkCloud Malware to Steal Keystrokes and Credentials gbhackers.com

Novartis Nabs FDA Approval for First-of-Its-Kind Drug for Chronic Hives
Novartis drug Rhapsido is now approved as a second-line treatment for chronic spontaneous urticaria, a rare inflammatory skin disease. Additional clinical trials are ongoing to